Severe Asthma

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in Russia

Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)

Defining the Severe Paediatric Asthma Endotype

Deployment o the Multidisciplinary Prospective Cohort Imminent

International Severe Asthma Registry: Canadian Cohort

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma

Severe Asthma Network Italy

Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Remission in Adults With Severe Asthma in Thailand

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients